Fig 4 -

<p>Incremental Cost-effectiveness scatter plot for both countries (a)India and (b) Brazil. The first two scatter plots in each figure show 1000Monte Carlo simulations for the incremental costs (USD, 2021) and incremental effectiveness in correct case diagnosed with that of Diaskintest and Cy-T...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Saima Bashir (9726310) (author)
مؤلفون آخرون:	Shehzad Ali (628091) (author), Seda Yerlikaya (13966305) (author), Mary Gaeddert (591524) (author), Lara Goscé (11485929) (author), Molebogeng X. Rangaka (9258426) (author), Claudia M. Denkinger (8790434) (author)
منشور في:	2024
الموضوعات:	Medicine Biotechnology Sociology Science Policy Infectious Diseases Virology Environmental Sciences not elsewhere classified Biological Sciences not elsewhere classified purified protein derivative probabilistic sensitivity analysis health system perspective decision tree model best performing igra study findings reveal tb gold plus standard e tb best performing skin approximately 8 usd tst );( b tb outperforms qft burden tb countries mycobacterium tuberculosis infection brazil </ p burden countries study evaluates tb infection tb ); new skin among skin 74 usd 6 usd 55 usd yet well xlink "> two high tbf due tbf )) release assays parameter variability feron elisa economic value diagnostic technologies comparing :(
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

Fig 4 -

مواد مشابهة